Klichinsky Michael bought CARM
January 31, 2024 · Form 4 insider transaction
Klichinsky Michael bought 170,500 shares of Carisma Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
170,500
Price
$0.00
Total value
N/A
InsiderKlichinsky Michael
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 31, 2024
Filing dateFebruary 2, 2024
Shares owned after170,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying this option vest over four years in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.